Trugman J, Finnegan M, Lipton R, et al. Efficacy, Safety, and Tolerability of Ubrogepant for the Acute Treatment of Migraine: Results from a Single Attack Phase II Study, ACHIEVE I. AAN 2018, emerging science abstract 008.
Subklinische manifestatie MS bij asymptomatische familieleden
jun 2017 | Multipele Sclerose